IDEAYA Biosciences Inc
F:30J
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
IDEAYA Biosciences Inc (30J) under the Base Case is 19.77 EUR per share.
Compared with the current market price of 23.54 EUR, the stock appears
Overvalued by 16% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What IDEAYA Biosciences Does
IDEAYA Biosciences is a biotechnology company that develops cancer drugs aimed at tumors with specific genetic weaknesses. Its work focuses on precision oncology, especially small-molecule medicines designed to block the pathways cancer cells depend on while sparing healthier cells. The company’s main assets are its drug candidates and the science behind matching the right drug to the right tumor type.
- Headquarters
- United States of America US
- Employees
- 145
- IPO date
- May 23, 2019
Balance Sheet
Continue 30J Research
Decided on IDEAYA Biosciences? Get an email when 30J reaches the price you’d buy at. Free with an account.
Other IDEAYA Biosciences listings
What is the Intrinsic Value of one 30J stock?
The intrinsic value for
IDEAYA Biosciences Inc (30J) under the Base Case is 19.77 EUR.
Is 30J stock undervalued or overvalued?
Compared with the current market price of 23.54 EUR, the stock appears Overvalued by 16% .